NIH-funded research R01 grant

Investigating how NgBR affects liver function and insulin resistance in diabetes

Official title: Role of NgBR in regulating hepatic gluconeogenesis and insulin resistance

Funded at NYU Long Island School of Medicine · NIH-11059136 · Data updated 2026-11-12

This study is looking at a protein called NgBR to see how it might help control insulin resistance and sugar production in the liver, which could lead to new ways to prevent or manage type 2 diabetes, especially for those at risk of obesity.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNYU Long Island School of Medicine
NIH-funded
Lab location1 site (Mineola, United States)
Project startApril 1, 2022
Project endMarch 31, 2026
Funding year2025
Award (this year)$546,459
NIH project number5R01DK132056-04
Project IDNIH-11059136 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who are at risk of or currently have obesity-related type 2 diabetes.

Less likely to help

Patients who do not have obesity-related type 2 diabetes or those with other unrelated metabolic disorders may not benefit from this research.

What this research studies

This research focuses on understanding the role of NgBR, a protein that may help regulate insulin resistance and glucose production in the liver. By studying how NgBR interacts with adiponectin and the AMPK pathway, the researchers aim to uncover mechanisms that could prevent obesity-related type 2 diabetes (T2D). The study involves animal models to observe changes in glucose levels and liver function when NgBR is altered. If successful, this research could lead to new strategies for managing or preventing T2D.

Why it matters

Potential benefit: If successful, this research could provide new insights into preventing or treating type 2 diabetes, potentially improving the lives of millions affected by this condition.

How similar studies have gone: Previous research has shown promising results in understanding the role of adiponectin and AMPK in diabetes, suggesting that this approach could yield valuable insights.

Where this research is happening

  • NYU Long Island School of Medicine
    Mineola, United States
    Active

Researchers

  • Principal investigator: Miao, Qing — NYU Long Island School of Medicine
  • Study coordinator: Miao, Qing

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.